Skip to content

Dilapan-S Osmotic Dilator in Pre-induction of Labor

Prospective Collection of Data About the Use of the Dilapan-S Osmotic Dilator in Pre-induction of Labor in Women With/Without Caesarean Section in Their History

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02098382
Enrollment
125
Registered
2014-03-28
Start date
2013-05-31
Completion date
2014-10-31
Last updated
2015-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine Cervical Incompetence

Keywords

Cervical ripening

Brief summary

Non-interventional prospective data collection designed to evaluate clinical outcome on the efficacy of the use of Dilapan-S in the indication of labor pre-induction in women with/without a history of Caesarean section. The evaluation will be based on prospective data collection in at least four obstetrics centers in the Czech Republic.

Detailed description

Nowadays there is a rising need for non-pharmacological cervical ripening methods as the use of prostaglandins is frequently limited by various contraindications. Dilapan-S is a hygroscopic uterine neck dilator. Its mode of action consists in the hydrophilic properties of the device absorbing fluids from surrounding tissue structures, thus expanding the volume of Dilapan-S sticks which subsequently exert radial pressure on the surrounding structures (uterine neck) to dilate progressively. Endocervical pressure on the uterine neck results not only in its mechanical dilatation but pressure on endocervical structures also stimulates the production of endogenous prostaglandins, which promote cervical ripening through its collagenolytic action. Although Dilapan-S is widely used in labor pre-induction, published study data comparing its clinical efficacy and safety in females with/without caesarean section in medical history are lacking.

Interventions

DEVICEDilapan-S

Dilapan-S synthetic osmotic dilator for cervical ripening prior to labor induction

Sponsors

Medicem International CR s.r.o.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

* Single pregnancy * Pregnancy more than 36 weeks * Vertex presentation of the fetus * Cervix Score less than 4 points

Exclusion criteria

* Contraindication to vaginal delivery * Pathological fetal station * States after uterine body surgery - except for Caesarean section * Clinical signs of uterine, vaginal or vulvar infection * Fetus hypoxia (KTG recording evaluated as pathological prior to pre-induction initiation)

Design outcomes

Primary

MeasureTime frameDescription
Cervix (Bishop) scoreBefore pre-induction of labor performance and up to 24 h after pre-induction of laborTo evaluate, based on the value obtained in the Cervix Score, the efficacy of use of the Dilapan-S device in the indication labor pre-induction, and to compare outcomes in patients with/without a history of Caesarean section.

Secondary

MeasureTime frameDescription
Uterine contractionsFrom Dilapan-S rods insertion up to 24 h during pre-induction of labor phaseTo compare these results in patients with/without Caesearean section in their medical history. Uterine hypertonus is diagnosed, when the number of uterine contractions is higher than 5 within 10 minutes (during pre-induction).
Apgar scoreAt 1st, 5th and 10th minute after deliveryTo compare these results in patients with/without Caesarean section in their medical history.
pH of the fetusUp to 10 minutes after deliveryTo compare the results in patients with/without caesarean section in their medical history. The rate of ceses with pH below 7,1.
Infection complications of mother / fetusUp to 5 days from the birthClinical signs of infection are defined as follows: 1. CRP levels \> 8 mg/l 2. Leukocyte count \> 18 x 109/l 3. Body temperature \> 37.5°C
Total duration of pre-inductionFrom Dilapan-S rods insertion up to 24 hoursTo compare these outcomes in patients with and without a history of Caesarean section.
Number of dilators insertedAt the moment of Dilapan-S insertion up to 24 hours until their removalExpected the insertion from 2 to 5 Dilapan-S rods. To compare these results in patients with/without Cesarean section in their medical history.
The course of delivery (vaginally or Caesarean section)From active phase of labor up to 1 day after deliveryTo compare the rate of vaginal delivery/Caesarean sections in patients with/without Caesarean section in their medical history.

Other

MeasureTime frameDescription
Patients´evaluation of pre-induction of labor with Dilapan-SFrom Dilapan-S insertion up to 24 h of duration of labor pre-induction phaseSubjective satisfaction Pain experienced during Dilapan-S insertion and pre-induction phase Quality of relax and sleep Frequency and intensity of uterine contractions during pre-induction
Course of removal of Dilapan-S rods after pre-inductionAt the moment of removal of Dilapan-S rods after labor pre-induction phase up to 1 day after deliveryThe evaluation of the course of removal of Dilapan-S after termination of preinduction by physician as very easy, easy, standard, with some complications or very complicated.
Occurance of complication of rupture of fetal sac due to the use of Dilapan-S or other complications related to the use of Dilapan-SFrom Dilapan-S rods insertion up to 24 h of duration of labor pre-induction phase

Countries

Czechia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026